All News

Wright Medical Group N.V. Reports 2019 First Quarter Financial Results

AMSTERDAM, The Netherlands, May 07, 2019 (GLOBE NEWSWIRE) — Wright Medical Group N.V. (WMGI) today reported financial results for its first quarter ended March 31, 2019 and reiterated its 2019 annual guidance.  Unless otherwise noted, all net sales growth rates in this release are stated on a constant currency basis.      Net sales totaled $230.1 million …

Orthofix Reports First Quarter 2019 Results

May 06, 2019  LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the first quarter ended March 31, 2019. Net sales were $109.1 million, earnings per share (“EPS”) was $0.05 and adjusted EPS was $0.27. “For the first quarter, our top and bottom line results were slightly better than anticipated and we remain confident …

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedures in the US West Coast

KFAR SABA, Israel, May 6, 2019 /PRNewswire/ — Scott A. Hacker, MD, a sports medicine orthopedic surgeon at Grossmont Hospital, San Diego, CA, enrolled and surgically treated the first four patients in the U.S. West Coast. The patients are taking part in CartiHeal’s FDA IDE randomized and controlled study, which aims to show superiority of the Agili-C™ cartilage regeneration implant …

Alphatec Announces Commercial Launch of PLIF IdentiTi™ Posterior Straight Porous Titanium Interbody System Implant and AlphaGRAFT® DBM Fiber

CARLSBAD, Calif., May 06, 2019 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial releases of its PLIF IdentiTi-PS Porous Titanium Interbody Implant System for Posterior Lumbar Interbody Fusion Procedures (PLIFs) and its AlphaGRAFT Demineralized Bone …

Astura Medical Receives FDA 510(k) Clearance For HALF DOME X Expandable Posterior Lumbar Interbody System

CARLSBAD, CA – May 3, 2019 – Astura Medical, a high-growth, innovative spine technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Half Dome X Expandable Posterior Lumbar Interbody System. The Half Dome X system delivers a new level of intraoperative flexibility and efficiency by providing infinitely …

Chief Artificial Disc Replacement Innovator Dr. Todd Lanman Selected as Los Angeles’ Premier Provider of New FDA-Approved Anatomical M6 Cervical Disc Device

LOS ANGELES (PRWEB) APRIL 23, 2019 Los Angeles spinal neurosurgeon Dr. Todd H. Lanman continues to be at the forefront of spinal artificial disc replacement technology, once again leading the release of a new FDA-approved disc replacement device with the M6-C, a device with the first-ever viscoelastic core, which for the first time will mimic the …

DiFusion Announces Data for ZFUZE Immuno-Stealth Surgical Polymer

May 03, 2019 AUSTIN, Texas–(BUSINESS WIRE)–DiFusion Technologies, Inc. today announced promising data for the company’s ZFUZE Immuno-Stealth™ Surgical Polymer. The data and the importance of the immune system response in new technologies such as ZFUZE were debated at the Castellvi Spine Symposium in Key West in April. The immune system plays a vital role in …

Misonix, Inc. Enters Into Definitive Agreement to Acquire Regenerative Medical Company Solsys Medical for Approximately $97 Million

FARMINGDALE, N.Y., May 02, 2019 (GLOBE NEWSWIRE) —  Misonix, Inc. (Nasdaq: MSON) (“Misonix”) a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it has entered into a definitive agreement with Solsys Medical, LLC (“Solsys”), a privately held regenerative medical company, to acquire Solsys in an all-stock transaction valued at …

Anika Reports First Quarter 2019 Financial Results

May 02, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today reported financial results for the first quarter ended March 31, 2019, and provided an update on its business progress in the period. “Anika is off to a strong …

Globus Medical Reports First Quarter 2019 Results

AUDUBON, Pa., May 02, 2019 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2019. Worldwide sales were $182.9 million, an increase of 4.9% as reportedFirst quarter net income was $33.2 million, a decrease of 16.0%Diluted earnings per share (EPS) was …

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1